Rewind Therapeutics

Foundation date

27/09/2017

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

We discover and develop innovative first-in-class remyelinating therapies for patients suffering from multiple sclerosis and other myelin-related diseases.

Latest news

  • Mayne Pharma and Mithra announce TGA approval of Nextstellis® oral contraceptive

    23 hours ago

  • Bone Therapeutics and Link Health sign a non-binding term sheet for the global rights of ALLOB

    23 hours ago

  • S-Biomedic announces topline results of a successful clinical study in acne

    Friday November 26th 2021

Jobs by Rewind Therapeutics